Trastuzumab for breast cancer-related carcinomatous meningitis.
Robins
H Ian
HI
Liu
Glenn
G
Hayes
Lori
L
Mehta
Minesh
M
D000911:Antibodies, Monoclonal / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000032:analysis / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000473:pathology*; D002277:Carcinoma / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary*; D002555:Cerebrospinal Fluid / Q000737:chemistry; D016903:Drug Monitoring / Q000379:methods; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D008279:Magnetic Resonance Imaging; D008577:Meningeal Neoplasms / Q000175:diagnosis / Q000188:drug therapy* / Q000556:secondary*; D008875:Middle Aged; D000068878:Trastuzumab
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D000068878:Trastuzumab